REG - Glanbia PLC - Director/PDMR Shareholding

GlanbiaAnnouncement

09/08/2019 15:00

RNS Number : 6104I
Glanbia PLC
09 August 2019
 


Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
 
 [This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
 



1


Details of the person discharging managerial responsibilities/person closely associated
 




a)


Name


 
Siobhán Talbot
 




 
 
 




2


Reason for the notification
 




a)


Position/status


 
 
Group Managing Director, Executive Director and Person Discharging Managerial Responsibility
 
 
 




b)


Initial Notification Amendment


 
 
Initial Notification
 
 




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


 
Glanbia plc
 




b)


LEI


 
635400SRMCBHVMSKJS84
 




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial  instrument,
type  of
instrument
Identification code


 
 
Ordinary  Shares of €0.06 each
 
ISIN: IE0000669501




b)


Nature of the transaction  


 
Purchase of 5,000 ordinary shares of €0.06 each.
 
 




c)


Price(s) and volume(s)


 



Price(s)


Volume(s)




 
€11.15 per share


 
5,000








d)


Aggregated information
- Aggregated volume
- Price


 
 



Price(s)


Volume(s)




€11.15 per share


5,000



 
 
 
 




e)


Date of the transaction


 
 
2019-08-08 - 11.26 AM (UTC)
 
 




f)


Place of the transaction


 
Dublin
 
 




g)


Additional Information


 
 
 



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGGRFLKGLZM